Sherry Glied and I have critiqued the recent analysis on the impact of Medicaid work requirements on poverty. It is linked here: : www.healthaffairs.org/content/fore...
Unfortunately, Professors Mulligan and Bai who appear to have led the work get a failing grade on this one.
Last wee Ben Graham and I released a paper examining R&D spending by large pharmaceutical manufacturers. We show that the evidence does not support the idea that R&D effort has declined as a result of the Inflation Reduction Act. In fact the evidence suggests that if anything, it has increased.
Today scientific American published my op ed on Medicaid cuts and the opioid epidemic. It can be found at www.scientificamerican.com/article/medi...
My colleague Yihan Shi and I posted the linked paper showing that all prescription drugs slated for Medicare negotiation and likely to soon be negotiated are making healthy returns on R&D investments. www.brookings.edu/articles/cum...
Thanks Ezra its a small effort on a huge problem
Christen Linke Young, Rachel Sachs and I just put out a paper reviewing issues related to adopting International Reference Prices for prescription drugs. The link is: www.brookings.edu/articles/int...
I posted a paper today with so e facts to highlight
Possible consequences of Medicaid cuts www.brookings.edu/articles/the...
Sherry Glied and I posted a blog noting that cuts to NIH and FDA are grounded in misunderstanding of the basis for grant programs and a failure to consider the health impacts of staff reductions at FDA. See www.brookings.edu/articles/the...
Today Sherry Glied and I posted a commentary on Health Affairs Forefront outlining how the HHS reorganization runs counter to RFK's stated goals for the department and any notion of improved efficiency. See the post at www.healthaffairs.org/content/fore...
The following paper may be of interest to folks following the IRA nam10.safelinks.protection.outlook.com?url=https%3A...